Search Results - "DUSENKA, ROBERT"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    Association of MDM2 T309G (rs2279744) Polymorphism and Expression Changes With Risk of Prostate Cancer in the Slovak Population by SIVONOVA, MONIKA KMETOVA, JURECEKOVA, JANA, KAPLAN, PETER, HIVES, MARK, GRENDAR, MARIAN, TOMASCOVA, ANNA, DUSENKA, ROBERT, DROBKOVA, HENRIETA, EVIN, DANIEL, KLIMENT, JAN

    Published in Anticancer research (01-11-2020)
    “…Background/Aim: The aim of this study was to evaluate the relationship between MDM2 T309G polymorphism and prostate cancer risk in the Slovak population and…”
    Get full text
    Journal Article
  6. 6

    Effect of CYP17 and PSA gene polymorphisms on prostate cancer risk and circulating PSA levels in the Slovak population by Sivoňová, Monika Kmeťová, Dobrota, Dušan, Dušenka, Róbert, Waczulíková, Iveta, Slezák, Peter, Matáková, Tatiana, Mahmoodová, Silvia, Mištuna, Dušan, Kliment, Ján

    Published in Molecular biology reports (01-08-2012)
    “…Cytochrome P-450c17α ( CYP17 ) and prostate-specific antigen ( PSA ) genes, which are involved in the androgen metabolism cascade, have been studied as…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Androgen receptor and soy isoflavones in prostate cancer by Sivoňov, Monika, Kapl n, Peter, Tatarkov, Zuzana, Lichardusov, Lucia, Dušenka, R bert, Jurečekov, Jana

    Published in Molecular and clinical oncology (01-02-2019)
    “…Androgens and androgen receptor (AR) play a critical role not only in normal prostate development, but also in prostate cancer. For that reason, androgen…”
    Get full text
    Journal Article
  10. 10

    Polymorphisms in the gene encoding CYP1A2 influence prostate cancer risk and progression by Vilčková, Marta, Škereňová, Mária, Dobrota, Dušan, Kaplán, Peter, Jurečeková, Jana, Kliment, Ján, Híveš, Márk, Dušenka, Róbert, Evin, Daniel, Brožová, Martina, Sivoňová, Monika

    Published in Oncology letters (01-02-2023)
    “…The role of the cytochrome P450 1A2 (CYP1A2) rs2472299, rs2470890 and rs11072508 polymorphisms in prostate cancer risk, disease progression and tumour…”
    Get full text
    Journal Article
  11. 11

    Role of Genetic Variations in CDK2, CCNE1 and p27KIP1 in Prostate Cancer by Híveš, Márk, Jurečeková, Jana, Kliment, Ján, Grendár, Marián, Kaplán, Peter, Dušenka, Róbert, Evin, Daniel, Vilčková, Marta, Holečková, Klaudia Híveš, Sivoňová, Monika Kmeťová

    Published in Cancer genomics & proteomics (01-05-2022)
    “…Background/Aim: Our aim was to investigate possible influences of genetic variants in genes involved in the G1/S transition [cyclin-dependent kinase-2 (CDK2),…”
    Get full text
    Journal Article
  12. 12

    Polymorphism of the SRD5A2 gene and the risk of prostate cancer by DUŠENKA, RÓBERT, TOMAŠKIN, ROMAN, KLIMENT, JÁN, DOBROTA, DUŠAN, DUŠENKOVÁ, SVETLANA, VILČKOVÁ, MARTA, SIVOŇOVÁ, MONIKA KMEŤ'OVÁ

    Published in Molecular medicine reports (01-12-2014)
    “…Androgens are actively involved in the development of the prostate gland and appear to be essential for prostate carcinogenesis. The product of the SRD5A2…”
    Get full text
    Journal Article
  13. 13

    The role of p21 3′UTR gene polymorphism in the risk of prostate cancer: A pilot study by SIVOŇOVÁ, MONIKA KMEŤOVÁ, VILČKOVÁ, MARTA, JUREČEKOVÁ, JANA, HATOK, JOZEF, DOBROTA, DUŠAN, DUŠENKA, RÓBERT, KLIMENT, JÁN

    Published in Molecular medicine reports (01-03-2013)
    “…The cell cycle regulator p21 plays an important role in regulating critical cell activities including cell cycle control, DNA repair and apoptosis…”
    Get full text
    Journal Article
  14. 14
  15. 15

    The role of p21 3'UTR gene polymorphism in the risk of prostate cancer: a pilot study by Sivoňová, Monika Kmetová, Vilčková, Marta, Jurečeková, Jana, Hatok, Jozef, Dobrota, Dušan, Dušenka, Róbert, Kliment, Ján

    Published in Molecular medicine reports (01-03-2013)
    “…The cell cycle regulator p21 plays an important role in regulating critical cell activities including cell cycle control, DNA repair and apoptosis…”
    Get full text
    Journal Article
  16. 16

    Role of Genetic Variations in CDK2 , CCNE1 and p27 KIP1 in Prostate Cancer by Híveš, Márk, Jurečeková, Jana, Kliment, Ján, Grendár, Marián, Kaplán, Peter, Dušenka, Róbert, Evin, Daniel, Vilčková, Marta, Holečková, Klaudia Híveš, Sivoňová, Monika Kmeťová

    Published in Cancer genomics & proteomics (01-05-2022)
    “…Our aim was to investigate possible influences of genetic variants in genes involved in the G /S transition [cyclin-dependent kinase-2 (CDK2), cyclin E1…”
    Get more information
    Journal Article